PLUS THERAPEUTICS, INC. (ticker: PSTV) is an NASDAQ-listed clinical biotech company. Its most recent SEC filing was a 10-Q dated 2026-05-15. DredgeCap's structured extraction of PSTV's SEC filings surfaces 5 active risk signals, including 3 delisting/deregistration signals, and 2 late-filing signals. PSTV reported $5.21M in revenue and -$22.39M for the period ending 2025-12-31, with operating cash flow of -$20.77M. Cash and equivalents stood at $4.26M (up 5500% year-over-year). Total assets of $16.32M exceed total liabilities of $12.33M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
5active risk signals
Key financials
Values sourced directly from SEC XBRL filings. YoY arrows compare the latest reported period to the same period one year prior on the same reporting concept.
Recent SEC filings
View all →| Form | Date | Accession | EDGAR |
|---|---|---|---|
| 10-Q | May 15, 2026 | 0001193125-26-226978 | view ↗ |
| 8-K | May 15, 2026 | 0001193125-26-226747 | view ↗ |
| 8-K | Apr 21, 2026 | 0001193125-26-165205 | view ↗ |
| 8-K | Apr 9, 2026 | 0001193125-26-148920 | view ↗ |
| 8-K | Apr 8, 2026 | 0001193125-26-146335 | view ↗ |
| 8-K | Apr 2, 2026 | 0001193125-26-140267 | view ↗ |
| 10-K | Mar 12, 2026 | 0001193125-26-104258 | view ↗ |
| 10-Q | Oct 30, 2025 | 0001193125-25-258596 | view ↗ |
| 10-Q | Aug 14, 2025 | 0000950170-25-108874 | view ↗ |
| 10-Q | May 30, 2025 | 0000950170-25-079738 | view ↗ |